Drugs News and Research

RSS

U.S. FDA approves generic Levaquin for treatment of bacterial infections

The U.S. Food and Drug Administration today approved the first generic versions of Levaquin, an antibiotic approved to treat certain infections in people ages 18 and older.

21 Jun 2011

Study finds link between energy drink consumption and substance use among musicians

Frequent use of energy drinks is associated with binge drinking, alcohol-related social problems and misuse of prescription drugs among musicians, according to researchers at the University at Buffalo's Research Institute on Addictions.

21 Jun 2011

Insight into why some people develop drug addiction

Researchers at the University of Cambridge have identified abnormal brain structures in the frontal lobe of cocaine users' brains which are linked to their compulsive cocaine-using behaviour. Their findings were published today, 21 June, in the journal Brain.

21 Jun 2011

Amylin to present data on investigational diabetes drug candidates at ADA annual meeting

Amylin Pharmaceuticals, Inc. today announced that the Company will present data for its two first-in-class diabetes drugs, BYETTA injection and SYMLIN injection, and its investigational diabetes drug candidates BYDUREON and exenatide once monthly at the 71st Scientific Sessions of the American Diabetes Association (ADA) being held in San Diego, CA from June 24 to June 28.

21 Jun 2011

Benitec’s pain program validated by independent study

Benitec Ltd (ASX:BLT), a world leader in RNA-based gene silencing for human therapeutics, announced that China-based researchers have proved the concept behind Benitec's in house neuropathic pain program.

20 Jun 2011

Home-based care increasingly seen as alternative to nursing homes

The health law includes provisions to assist people who want to stay in their homes longer. Meanwhile, the Chicago Sun-Times reports on knowlege gaps among adult children who may become caregivers to aging parents.

20 Jun 2011

FDA's new strategy calls for coalitions of international regulators, increased data sharing

The U.S. Food and Drug Administration today unveiled a new strategy to meet the challenges posed by rapidly rising imports of FDA-regulated products and a complex global supply chain in a report called the "Pathway to Global Product Safety and Quality."

20 Jun 2011

NanoViricides plans to lease new cGMP manufacturing and lab space

NanoViricides, Inc. announced today that it will be leasing new space for cGMP production of its nanoviricides drug candidates against various viral diseases.

20 Jun 2011

Supreme Court ruling would affect around 10,000 Reglan-metoclopramide lawsuits

The U.S. Supreme Court is expected to rule shortly on whether generic drug companies must adequately warn doctors about new or revised risks to patients who have taken the drugs they make. (Pliva v Mensing No. 09-993, Actavis v Mensing No.08-3850 and Actavis v Demahy No. 09-1501) All three cases involve patients who took metoclopramide, the generic version of the brand-name drug Reglan.

20 Jun 2011

Pulmatrix introduces novel iSPERSE inhaled dry powder drug delivery platform

Pulmatrix, a clinical stage biotechnology company discovering and developing a new class of therapies for the prevention, treatment and control of respiratory diseases, today announced the launch of iSPERSE, the company's novel inhaled dry powder drug delivery platform.

20 Jun 2011

UK’s first larynx transplant

In a first, UK will get its voicebox or larynx transplant in less than a year after the Royal College of Surgeons gave its seal of approval for trials to take place. A report by the college said the pioneering procedure could help people who had cancer of the larynx to speak and breathe normally again.

19 Jun 2011

Drug addiction management costs UK £3.6bn a year: Report

According to a latest report from the think tank the Centre for Policy Studies (CPS), drug addiction costs £3.6bn a year for both treating problem drug users and keeping them on benefits. The study by has criticised government plans to change the way authorities tackle drug addiction. It claims the plans for payment-by-results schemes are “doomed to failure, not least because they are being run by the very organizations responsible for the current failure of policy”.

19 Jun 2011

Controversy over F.D.A.-Avastin decision to reignite June 28-29 with new round of hearings

Controversy over the F.D.A.'s proposal to withdraw approval of Avastin for breast cancer treatment will reignite June 28-29 with a new round of hearings. One oncologist who will be monitoring the hearings is Dr. Frederick C. Tucker Jr. of Fredericksburg Oncology in Virginia, whose recent New York Times op ed defended the F.D.A.'s position on scientific grounds.

18 Jun 2011

Dems introduce bills to push for Medicare negotiated drug pricing

Congressional Democrats have introduced legislation to let Medicare negotiate prescription drug prices - a move that could result in significant savings, the bill supporters say. They are urging that their measure be included in the effort to raise the debt ceiling.

18 Jun 2011

PDA urges public to undergo screening for oral cancer

Oral cancer claims more lives than leukemia, Hodgkin's lymphoma, laryngeal cancer, testicular cancer, thyroid cancer, or skin cancer. In 2010, approximately 36,540 Americans were diagnosed with this largely preventable type of cancer that affects the mouth and throat; 7,880 died of the disease. Early detection is essential to dramatically reduce the number of deaths from oral cancer.

18 Jun 2011

Study shows increase in emergency department visits for drug-related suicide attempts among men

A new national study shows that from 2005 to 2009 there was a 55 percent increase in emergency department visits for drug related suicide attempts by men aged 21 to 34 -- from 19,024 visits in 2005 to 29,407 visits in 2009. In 2009, there were a total of 77,971 emergency department visits for drug-related suicide attempts among males of all ages.

18 Jun 2011

Scientists create first roadmap to understand estrogen signaling in breast cancer cells

The first roadmap to mathematical modeling of a powerful basic "decision circuit" in breast cancer has been developed and published in Nature Reviews Cancer.

18 Jun 2011

White House focuses on prevention with release of national strategy

Described as a way to improve the nation's prosperity, the Obama administration announced a sweeping plan to emphasize health promotion and disease prevention for all walks of life.

17 Jun 2011

Sunshine enters Adva-27a cancer research and development agreement with The Jewish General Hospital

Sunshine Biopharma, Inc. a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has executed an agreement with The Jewish General Hospital, one of McGill University's Hospital Centers, to conduct the necessary research and development to advance Sunshine's lead compound, Adva-27a, through the various stages of preclinical studies and Phase I clinical trials.

17 Jun 2011

NASDAQ halts Regeneron's common stock

Regeneron Pharmaceuticals, Inc. announced that NASDAQ has halted trading of the company's common stock.

17 Jun 2011

Drugs News and Research

U.S. FDA approves generic Levaquin for treatment of bacterial infections

Study finds link between energy drink consumption and substance use among musicians

Insight into why some people develop drug addiction

Amylin to present data on investigational diabetes drug candidates at ADA annual meeting

Benitec’s pain program validated by independent study

Home-based care increasingly seen as alternative to nursing homes

FDA's new strategy calls for coalitions of international regulators, increased data sharing

NanoViricides plans to lease new cGMP manufacturing and lab space

Supreme Court ruling would affect around 10,000 Reglan-metoclopramide lawsuits

Pulmatrix introduces novel iSPERSE inhaled dry powder drug delivery platform

UK’s first larynx transplant

Drug addiction management costs UK £3.6bn a year: Report

Controversy over F.D.A.-Avastin decision to reignite June 28-29 with new round of hearings

Dems introduce bills to push for Medicare negotiated drug pricing

PDA urges public to undergo screening for oral cancer

Study shows increase in emergency department visits for drug-related suicide attempts among men

Scientists create first roadmap to understand estrogen signaling in breast cancer cells

White House focuses on prevention with release of national strategy

Sunshine enters Adva-27a cancer research and development agreement with The Jewish General Hospital

NASDAQ halts Regeneron's common stock

Drug Discovery - Second Edition eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News